Wright Petitions FDA To Deny Smith & Nephew’s Hip Resurfacing PMA

Approval of Smith & Nephew's PMA for its Birmingham hip resurfacing system would set a "dangerous precedent," orthopedic competitor Wright Medical contends in written comments to FDA

More from Archive

More from Medtech Insight